Navigation Links
Zimmer Reports Fourth Quarter and 2009 Financial Results
Date:1/28/2010

provided by operating activities 1,117.5 1,038.1 ------- ------- Cash flows provided by (used in) investing activities Additions to instruments (123.7) (237.9) Additions to other property, plant and equipment (105.1) (250.0) Acquisition of intellectual property rights (35.8) (109.4) Purchases of certificates of deposit (66.4) - Proceeds from sale of other assets - 54.9 Abbott Spine acquisition, net of acquired cash - (363.0) Investments in other assets (50.2) (18.8) ----- ----- Net cash used in investing activities (381.2) (924.2) ------ ------ Cash flows provided by (used in) financing activities Net proceeds (payments) under revolving credit facility (330.0) 330.0 Proceeds from employee stock compensation plans 9.5 57.0 Excess income tax benefits from employee stock compensation plans 0.4 6.5 Repurchase of common stock (923.7) (737.0) Proceeds from issuance of notes 998.8 - Debt issuance costs (8.5) - Acquisition of noncontrolling interest (8.6) - ---- ---- Net cash used in financing activ
'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related medicine technology :

1. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Fourth Quarter and Full-Year 2009 Results
2. Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer
3. Zimmer Holdings to Present at 21st Annual Piper Jaffray Health Care Conference
4. Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes
5. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2009 Results
6. Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmers Trabecular Metal(TM) Technology
7. Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results
8. Lilly Reports Fourth-Quarter and Full-Year 2009 Results
9. P&G Reports Accelerated Sales and Unit Volume Growth
10. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
11. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic ... . (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) ... policy support, China,s orthopedic instrument ... total market size rising from 3.28 billion yuan in ...
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today announced ... older adults suffering from the severe cold weather that has ... committed to helping those in need; so to support these ... contributions up to $250,000, which could mean up to $500,000 ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces ... condition to the announced tender offer for all of the outstanding ... result of the waiver, the transaction is no longer conditional on ... January 24, 2014 following the currently scheduled expiration time, subject to ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... YORK, Feb. 15, 2012 Delcath Systems, Inc. (NASDAQ: ... ( Instituto Europeo di Oncologia – IEO) introduced ... a Feb. 15 press conference and discussed the status ... CHEMOSAT is a critical new treatment option for patients ...
... ERT (NASDAQ: ERT ) announced today that it ... year 2011 Monday, February 27, after the market closes. After ... 5:00 PM ET that day. For the conference ... United States or 1-412-858-4600 when calling internationally. There will be ...
Cached Medicine Technology:Delcath CHEMOSAT Presented as Innovative Treatment for Liver Metastases by European Institute of Oncology 2Delcath CHEMOSAT Presented as Innovative Treatment for Liver Metastases by European Institute of Oncology 3Delcath CHEMOSAT Presented as Innovative Treatment for Liver Metastases by European Institute of Oncology 4ERT to Report Fourth Quarter and Full Year 2011 Operating Results 2
(Date:4/24/2014)... Ill. It is better to give than to receive ... giving, a new study suggests. , The study found that ... as giving their money to family members, are less likely ... from taking risks or keeping the money for themselves. , ... the National Academy of Sciences . , The study focused ...
(Date:4/24/2014)... Ore. An Oregon State University researcher has found ... of the symptoms of autism spectrum disorder in very ... be the first to show a direct relationship between ... fine and gross motor skills should be included in ... MacDonald, an assistant professor in OSU,s College of Public ...
(Date:4/24/2014)... University of York reveals that a process that forms ... system may also play a pivotal role in the ... by Dr Will Brackenbury, a Medical Research Council Fellow ... how voltage-gated sodium channels assist in the metastasis of ... of excitable cells, such as neurons, where they are ...
(Date:4/23/2014)... 2014 Pregnant immigrants from Sub-Saharan Africa, Latin ... during pregnancy, according to new research from St. ... the British Journal of Obstetrics and Gynaecology ... rates among immigrants and native-born women in six ... Sweden, Spain (Catalonia and Valencia) and the United ...
(Date:4/23/2014)... National Institute of Arthritis and Musculoskeletal and Skin Diseases ... Ross Prize in Molecular Medicine, conferred by the Feinstein ... award will be given on June 9 at the ... scientific presentations by Dr. O,Shea and other prominent researchers. ... , The award, which includes a $50,000 prize from ...
Breaking Medicine News(10 mins):Health News:Study: Altruistic adolescents less likely to become depressed 2Health News:Motor skill deficiencies linked to autism severity in new research 2Health News:Breast cancer replicates brain development process 2Health News:Pregnancy complications may be more common in immigrants from certain regions 2Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2
... , AUDUBON, Pa., June 2 Globus Medical, Inc., the ... announced the launch of the COALITION(TM) ACDF Spacer System. ... provide the biomechanical strength of a traditional ACDF with less ... , The COALITION(TM) technology combines a PEEK interbody ...
... June 2 Cordex Pharma, Inc. (OTC Bulletin Board: ... Administration (FDA) has approved the design of pivotal, Phase ... an antiarrhytmic drug for the acute treatment of patients ... Assessment (SPA) process. , , ATPace(TM) is ...
... iMedica Corporation , a leading developer ... participation in the American College of Physicians ... Designed to assist physicians in choosing the best EHR for ... standards. The EPP provides detailed information to ACP members who ...
... Planned Spinoff of CareFusion Corporation , , DUBLIN, Ohio, ... and services that improve the safety and productivity of health ... quarterly dividend to $0.175 per share, or $0.70 per share ... announcement is particularly meaningful in that it comes in advance ...
... Medical, Inc. (Nasdaq: SLTM ), a global leader ... present at the Eight Annual Needham Life Sciences Conference at ... scheduled for 9:30 a.m. Eastern Time on Thursday, June 11, ... Officer, will review the company,s business strategy and recent corporate ...
... if you can find one , , BALTIMORE, June 2 ... late February, the Centers for Disease Control (CDC) says there are ... time of year. According to health officials, it is not too ... , Those who are in higher risk groups should receive ...
Cached Medicine News:Health News:Globus Medical Announces Launch of COALITION(TM) ACDF Spacer System 2Health News:Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM) 2Health News:Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM) 3Health News:Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM) 4Health News:iMedica Participates in American College of Physicians' EHR Partners Program 2Health News:iMedica Participates in American College of Physicians' EHR Partners Program 3Health News:Cardinal Health Increases Quarterly Dividend By 25 Percent 2Health News:Cardinal Health Increases Quarterly Dividend By 25 Percent 3Health News:Cardinal Health Increases Quarterly Dividend By 25 Percent 4Health News:Solta Medical, Inc. to Present at 8th Annual Needham Life Sciences Conference 2Health News:Seasonal Flu Lingers 2
... Our variable volume Finnpipette ... in a high performance pipette. ... colour-coded volume range, ensures quality, ... identification of the volume range ...
A Biplane Pediatric TEE transducer....
Super High Density, multi-frequency, convex array transducer for scanning during craniotomies. Same footprint as the UST-987-7.5 but with stronger penetration for deep cavernous tumors and other deep...
... Super High Density, multi-frequency, linear ... the first company to introduce ... and, as a result, changed ... and true workhorse has withstood ...
Medicine Products: